ESE. S. Sorozhkina

E. S. Sorozhkina

*This is an algorithmically generated author record based on publicly available information.

E. S. Sorozhkina has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Features of local and systemic production of major immune response cytokines in epithelial lacrimal gland tumors

    by A.G. Amiryan, S.V. Saakyan, N.V. Balatskaya, M.YU. Gusakova, E.S. Sorozhkina

    Investigation of the cytokine profile in tear fluid (TF) as a local environment, as well as in blood serum (BS), which reflects systemic immune status, may provide valuable information on the pathogenetic features and biological behavior of epithelial lacrimal gland tumors (LGTs). Objective. The study aimed to investigate changes in the levels of key cytokines associated with the immune response (IL-6, TNF-α, IL-2, IFN-γ, IL-17A, IL-4, IL-10) in TF and BS of patients with epithelial LGTs. Material and methods. The study examined 21 participants, including 10 healthy volunteers and 11 patients with epithelial LGTs (pleomorphic adenoma (PA) was diagnosed in 6 cases and lacrimal gland cancer (LGC) — in 5 cases). Cytokine levels in test samples were determined by multiplex analysis (CBA platform) using a flow cytometer. The analysis accounted for both the concentration of immunomediators and the frequency of their detection in the tested material. Results. Patients with PA and LGC showed changes in both the qualitative and quantitative composition of proinflammatory and anti-inflammatory mediators. In TF of patients with LGC, the highest concentrations of IL-6, TNF-α, IL-17A, and IL-10 were observed, mainly on the affected side. Patients with PA also showed elevated levels of IL-6, TNF-α, and IL-17A compared with the corresponding control values, but cytokine activation was less pronounced than in LGC. The analysis showed that assessment of TNF-α levels in TF is the most promising diagnostic marker of LGC: elevated concentrations of this cytokine were detected on the tumor side in all patients and were almost 20-fold higher than in PA (p<0.05 when comparing LGC patients with controls and the tumor side in LGC with PA). In BS the differences between the groups were less pronounced and not indicative. Conclusion. The obtained data allow the local cytokine profile to be considered as an additional noninvasive tool for differential diagnosis between benign and malignant epithelial LGTs.

  • Open Access

    Clinical Variations of Uveitis in Immuno-Inflammatory Diseases. Review of the Literature. Part 2

    by G. A. Davydova, T. A. Lisitsyna, L. A. Kovaleva, E. S. Sorozhkina, A. A. Zaitseva, A. A. Baisangurova

    In the previous part of the review clinical and diagnostic aspects of some non-infectious uveitis in patients with immunoinflammatory diseases were discussed. In this part we proceed the discussion of ocular manifestations of a number of other immunoinflammatory conditions. In addition to uveitis associated with spondyloarthropathies, rheumatoid arthritis, Still’s disease, juvenile idiopathic arthritis and systemic sarcoidosis described in the previous part, ocular manifestations are also common in systemic vasculitis, systemic lupus erythematosus, Vogt—Koyanagi—Harada syndrome. Despite the numerous diagnostic schemes and therapy algorithms developed to date, much in the pathogenesis of uveitis associated with immuno-inflammatory diseases remains unclear. The need to develop personalized and multidisciplinary approaches for the treatment and diagnosis of non-infectious uveitis in numerous systemic immunoinflammatory diseases remains relevant. In-depth understanding of etiopathogenetic mechanisms of immunoinflammatory processes will allow to develop new approaches in the treatment of patients with uveitis.


  • Open Access

    Clinical features of Behcet’s uveitis in patients with herpesvirus reactivation

    by V. V. Neroev, E. S. Sorozhkina, G. I. Krichevskaya, N. V. Balatskaya, G. A. Davydova, T. A. Lisitsyna

    Purpose. To study the possible impact of human herpes viruses (HHV) reactivation: herpes simplex virus type 1 (HSV 1), type 2 (HSV 2), cytomegalovirus (CMV) and Epstein — Barr virus (EBV) on the clinical course of uveitis in Behcet's disease (BD). Material and methods. Serum samples of 106 BD patients (ave. age 39) with uveitis were examined for the presence of antibodies — serological markers of chronic HHV infection and reactivation. Results. In 65 patients (25 with active uveitis (UA), 40 with uveitis remission (UR)), HHV reactivation was detected (mainly HSV 1, less often HSV 2, CMV and EBV — in individual cases), 41 patients had chronic HHV (17 with UA, 24 with UR). Certain clinical symptoms of uveitis were found to depend on HHV activity. Clinical signs of active uveitis (cells in the vitreous body), as well as severe irreversible changes (social blindness and low vision) were significantly more frequently detected in cases of HHV reactivation (p < 0.05) than in chronic HHV. The data obtained allow us to suggest, with some caution, that a subclinical HHV reactivation which stays after the onset of clinical uveitis remission, is an important factor of postuveal complications that are mainly manifested during remission. These complications include epiretinal fibrosis, pronounced optic nerve atrophy, and vasculitis (arterial and venous occlusion). Conclusion. The remission period in patients with subclinical herpesvirus activity is less favorable than in patients without serological markers of HHV reactivation. HHV reactivation that persists after uveitis activity is stopped can contribute to sudden exacerbations of uveitis.


  • Open Access

    Clinical Variations of Uveitis in Immuno-Inflammatory Diseases. Review of the Literature. Part 1

    by G. A. Davydova, T. A. Lisitsyna, L. A. Kovaleva, E. S. Sorozhkina, A. A. Zaitseva, A. A. Baisangurova

    Non-infectious uveitis is one of the main and insufficiently studied causes of disability and blindness in patients with immuno-inflammatory diseases. Uveitis associated with spondyloarthritis, Behcet’s disease, juvenile idiopathic arthritis, systemic sarcoidosis and Vogt-Koyanagi-Harada syndrome are described more often and better than others, but the pathogenesis of different variants of their course is not well understood. Also, there remains a need to study the clinical and pathogenetic features of uveitis in rare autoimmune inflammatory diseases. Despite the currently existing diagnostic and therapeutic schemes, further study of the pathogenesis of uveitis associated with immune-inflammatory diseases is required, the research of a personalized approach and an algorithm for joint multidisciplinary diagnosis by specialists in various fields. A deeper understanding of the specific pathogenetic mechanisms will reveal new possibilities in the treatment of patients with autoimmune uveitis. This article is devoted to the current clinical and differential diagnostic aspects, common features and distinctive features associated with various variants of the course of non-infectious uveitis in patients with immuno-inflammatory diseases.